Drugs / Hyruan-One
last change Dec 2023 re-read 9 days ago

Hyruan-One

Developed for
osteoarthritis, knee
Investigated by
Thammasat University

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03484091 Apr 2018 → Jun 2023 osteoarthritis, knee Thammasat University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Hyruan-One ClinicalTrials.gov intervention name — accepted as the source's own label NCT03484091 ↗
Route Other “intra-articular knee injection” NCT03484091 ↗